DSM-Firmenich AG is a Swiss-Dutch chemical company. It was formed on 9 May 2023[1] through the merger of Royal DSM and the Swiss company Firmenich. The company is listed on Euronext Amsterdam and is a constituent of the AEX index.
History
The announcement of the merger between DSM and Firmenich was first made in 2022[2] with a goal of establishing a leading nutrition and personal care ingredients company. The merger was considered by both organizations to be a "merger of equals"[3]. The merger was completed on 9 May 2023[1].
On 30 May 2024, a new headquarters in Maastricht was officially opened by Queen Máxima of the Netherlands.[4]
On 11 February 2025, Novonesis reached an agreement with the company to acquire its shares in the Feed Enzyme Alliance for €1.5 billion.[5] The agreement would dissolve the Alliance and have Novonesis take over all sales and distribution activities.
Activities
The company has over 300 locations in more than sixty countries.[6]
Corporate activities are divided into three business units[6]: Perfumery & Beauty; Health, Nutrition, and Care; and Taste, Texture & Health.
See also
References
- Firmenich completes merger of equals with DSM dsm-firmenich, retrieved 2026-02-05^
- Alex Scott. DSM to merge with fragrance maker Firmenich Chemical & Engineering News, 2025-01-21, retrieved 2026-02-05^
- DSM Firmenich Merger Media Presentation DSM-Firmenich, 2022-05-31, retrieved 2026-02-04^
- Koningin Maxima opent nieuw hoofdkantoor dsm-firmenich in Wyck rtvmaastricht.nl, 2024-05-30^
- Stine Jacobsen. Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6 bln Reuters, retrieved 2026-02-04^
- dsm-firmenich Integrated Annual Report 2024 dsm-firmenich Integrated Annual Report 2024, retrieved 2026-02-05^